2-[(1R)-1-fluoroethyl]-5-[[6-(4-methoxypyrrolo[2,1-f][1,2,4]triazin-5-yl)-2-methyl-imidazo[4,5-b]pyridin-1-yl]methyl]-1,3,4-oxadiazole

ID: ALA5202010

PubChem CID: 138522180

Max Phase: Preclinical

Molecular Formula: C19H17FN8O2

Molecular Weight: 408.40

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ncnn2ccc(-c3cnc4nc(C)n(Cc5nnc([C@@H](C)F)o5)c4c3)c12

Standard InChI:  InChI=1S/C19H17FN8O2/c1-10(20)18-26-25-15(30-18)8-27-11(2)24-17-14(27)6-12(7-21-17)13-4-5-28-16(13)19(29-3)22-9-23-28/h4-7,9-10H,8H2,1-3H3/t10-/m1/s1

Standard InChI Key:  OENNTZBJPRRGFL-SNVBAGLBSA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   -1.4267    0.0255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7121    0.4378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0002    0.0259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0002   -0.7992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7103   -1.2110    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4267   -0.8029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7845   -1.0542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7845    0.2809    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2695   -0.3866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0946   -0.3866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9980    1.0779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7951    1.2915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0906    2.0615    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.9144    2.0184    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1278    1.2217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4361    0.7725    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9249    1.0081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5084    1.5916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1385    0.2111    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1413    0.4381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8948    0.1027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4467    0.7156    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0343    1.4299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2275    1.2584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1496   -0.6817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9565   -0.8532    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5084   -0.2403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2535    0.5441    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5665   -1.2649    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7799   -2.0615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  4  7  1  0
  3  8  1  0
  8  9  1  0
  9  7  2  0
  9 10  1  0
  8 11  1  0
 11 12  1  0
 13 12  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 12  1  0
 15 17  1  0
 17 18  1  0
 17 19  1  1
  1 20  1  0
 21 20  2  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 20  1  0
 21 25  1  0
 26 25  2  0
 27 26  1  0
 28 27  2  0
 22 28  1  0
 25 29  1  0
 29 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5202010

    ---

Associated Targets(Human)

CLK2 Tchem Dual specificity protein kinase CLK2 (3942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 408.40Molecular Weight (Monoisotopic): 408.1459AlogP: 2.92#Rotatable Bonds: 5
Polar Surface Area: 109.05Molecular Species: NEUTRALHBA: 10HBD:
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.09CX LogP: 1.17CX LogD: 1.17
Aromatic Rings: 5Heavy Atoms: 30QED Weighted: 0.44Np Likeness Score: -1.60

References

1. Tang J, Xie Y, Huang J, Zhang L, Jiang W, Li Z, Bian J..  (2022)  A critical update on the strategies towards small molecule inhibitors targeting Serine/arginine-rich (SR) proteins and Serine/arginine-rich proteins related kinases in alternative splicing.,  70  [PMID:35863237] [10.1016/j.bmc.2022.116921]

Source